NEW YORK, April 17, 2017 /PRNewswire/ --
Stock-Callers.com today presents the following Medical Laboratories and Research equities for review: Agilent Technologies
Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), Quintiles IMS Holdings Inc. (NYSE: Q), and PAREXEL International Corp.
(NASDAQ: PRXL). These stocks are part of the Healthcare sector, which has received an "Outperform" rating from Charles Schwab on April 13 th, 2017. As per the research firm, health
care companies' balance sheets are solid, their stocks have offered attractive dividend yields, the sector's overall cost
structure appears to have improved, and demand for health care products and services appears to be on the rise. Learn more about
these stocks by downloading their free report at:
http://stock-callers.com/registration
Agilent
Santa Clara, California headquartered Agilent Technologies Inc.'s stock finished last
Thursday's session 0.42% lower at $52.33. A total volume of 863,880 shares was traded. The
Company's shares have advanced 8.12% over the previous three months and 15.14% since the start of this year. The stock is trading
above its 50-day and 200-day moving averages by 1.12% and 10.38%, respectively. Additionally, shares of Agilent Technologies,
which provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide, have a
Relative Strength Index (RSI) of 48.45.
On March 20 th, 2017, Agilent Technologies announced that Samraat "Sam" Raha has been
named Senior Vice President of strategy and corporate development, reporting to Agilent President and CEO Mike McMullen. Raha will serve as strategic lead and advisor to the CEO and executive team in developing the
Company's overall growth strategy, including leading its mergers and acquisitions plans globally. The free research report on A
is available at:
http://stock-callers.com/registration/?symbol=A
Thermo Fisher
On Thursday, shares in Waltham, Massachusetts headquartered Thermo Fisher Scientific Inc.
ended the session 0.18% lower at $152.18. The stock recorded a trading volume of 934,603 shares.
The Company's shares have gained 4.35% in the previous three months and 7.95% on an YTD basis. The stock is trading 0.66% above
its 200-day moving average. Moreover, shares of Thermo Fisher Scientific, which provides analytical instruments, equipment,
reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo
Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide, have an RSI of 35.21.
On March 31 st, 2017, Thermo Fisher Scientific announced that it will release its
financial results for Q1 before the market opens on Wednesday, April 26 th, 2017, and
will hold a conference call on the same day at 8:30 a.m. ET. The call can be accessed live under
the "Investors" section of the Company's website. The complimentary report on TMO can be downloaded at:
http://stock-callers.com/registration/?symbol=TMO
Quintiles IMS
Durham, North Carolina headquartered Quintiles IMS Holdings Inc.'s shares gained 0.36%,
closing the session at $78.95, with a total trading volume of 748,509 shares. The stock has gained
2.28% over the previous three months and 3.81% on an YTD basis. The Company's shares are trading 0.26% and 2.94% above their
50-day and 200-day moving averages, respectively. Additionally, shares of Quintiles IMS Holdings, which provides integrated
information and technology-enabled healthcare services in the Americas, Europe, Africa, and Asia/Pacific, have an RSI of 46.42.
On March 31 st, 2017, research firm Credit Suisse initiated an 'Outperform' rating on
the Company's stock, with a target price of $89 per share. Visit us today and download our complete
research report on Q for free at:
http://stock-callers.com/registration/?symbol=Q
PAREXEL
Last Thursday at the close, shares in Waltham, Massachusetts headquartered PAREXEL
International Corp. recorded a trading volume of 620,643 shares, and ended the session 1.18% lower at $61.10. The stock is trading below its 50-day moving average by 4.50%. Shares of the Company, which provides
clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products
and services for pharmaceutical, biotechnology, and medical device industries worldwide, have an RSI of 34.18.
On March 23 rd, 2017, research firm Mizuho initiated a 'Neutral' rating on the
Company's stock, with a target price of $86 per share.
On April 03 rd, 2017, PAREXEL International announced that it was named a top
contract research organization (CRO) in the CenterWatch 2017 Global Investigative Site Relationship Survey. The Company ranked
among the top five highest-rated CROs for the overall quality of its direct working relationships with investigative
sites. Get free access to your technical report on PRXL at:
http://stock-callers.com/registration/?symbol=PRXL
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES :
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a
third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on
analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed
any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently
reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or
interfere in the application of such procedures by the third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or
the Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing
of the information, or (2) warrant any results from use of the information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities
mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers
in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you ' re
a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between
09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA